1. CYP27A1/27HC/SREBP2 axis is a novel therapeutic target in prostate cancer. (December 2016) Authors: Alfaqih, M.; Nelson, E.R.; Liu, W.; Safi, R.; Jasper, J.S.; Macias, E.; Geradts, J.; Chang, C.Y.; McDonnell, D.P.; Freedland, S. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer. Issue 5 (2nd August 2017) Authors: Kadara, H.; Nemer, G.; Safi, R.; Rebeiz, N.; Daou, L.; Delbani, D.; Btadini, W.; Abbas, O.; Tofaili, M.; Bitar, F.; Kibbi, A.G.; Shimomura, Y.; Kurban, M. Journal: Clinical genetics Issue: Volume 92:Issue 5(2017) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0042 Evidence of netosis in circulating neutrophils and skin lesions with vasculitis and panniculitis in behÇet's disease. (12th June 2018) Authors: Kallas, R.; Safi, R.; Hamam, R.; Uthman, I.; Nassar, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗